Skip to main content

Pining for Truffles, Mycorrhiza Biotech Achieves First Harvest

When Nancy Rosborough read an article in the Washington Post about growing truffles, a gourmet delicacy that’s normally harvested from the wild, the novel idea took root as a Burlington biotech company.

NCBiotech-funded Companies Raise $11 Million in Latest Quarter

Seventeen bioscience companies that previously received funding from the North Carolina Biotechnology Center raised nearly $11 million in follow-on funding from other sources in the second quarter of the 2016-17 fiscal year that ended Dec. 31.

NCBiotech Awards $1.4 Million in Latest Quarter

The North Carolina Biotechnology Center awarded 13 grants and loans totaling $1.4 million to universities and bioscience companies in the second quarter of its 2016-2017 fiscal year ending Dec. 31.

Locus Biosciences Lifts Lid on Crafty CRISPR to Bust Bad Bacteria

Raleigh bioscience startup Locus Biosciences, a spinout of North Carolina State University, is using a version of the hot gene-editing technology called CRISPR to cut a new path to the discovery and development of novel antibiotics.

Two FDA Chiefs, Other Luminaries to Address CED Life Science Conference

By Barry Teater, NCBiotech writer

Past and present commissioners of the U.S. Food and Drug Administration, both with ties to Duke University, are among the speakers headlining the Council for Entrepreneurial Development’s 26th annual Life Science Conference next month in Raleigh.

UNC Nobel Laureate Oliver Smithies Dead at 91

Oliver Smithies, D.Phil., who was recruited to North Carolina with grant funding from the North Carolina Biotechnology Center and won the Nobel Prize in Physiology or Medicine 20 years later, died today at the age of 91.

New G1 Trials Target Breast Cancer

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, is expanding its search for new anti-cancer weapons by launching three more clinical trials targeting breast cancer.

Durham's GeneCentric Gets Bristol-Myers Squibb Buy-In

Durham’s GeneCentric Diagnostics has received an undisclosed sum of equity funding for a biomarker research collaboration with pharmaceutical giant Bristol-Myers Squibb.

Viamet Reports Positive Clinical Results for Anti-fungal Compound

Durham-based Viamet Pharmaceuticals has reported positive results from clinical trials of its lead product candidate for the treatment of two common fungal infections.

Cohera Medical Begins Clinical Trial of Surgical Sealant

Cohera Medical Inc., a medical-device company that relocated to Raleigh from Pittsburgh a year ago, has enrolled the first patient in a clinical trial of its Sylys Surgical Sealant.


Subscribe to RSS - Life Sciences